{"id":"https://openalex.org/W2739640451","doi":"https://doi.org/10.1158/1538-7445.am2017-2197","title":"Abstract 2197: Characterization of immunoliposomes as delivery vehicles for the Rac inhibitor Ehop-016 in HER2 type breast cancer","display_name":"Abstract 2197: Characterization of immunoliposomes as delivery vehicles for the Rac inhibitor Ehop-016 in HER2 type breast cancer","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2739640451","doi":"https://doi.org/10.1158/1538-7445.am2017-2197","mag":"2739640451"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-2197","doi":"https://doi.org/10.1158/1538-7445.am2017-2197","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2197","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020224582","display_name":"Michael John Rivera-Robles","orcid":"https://orcid.org/0000-0002-0646-8670","observed_orcids":["https://orcid.org/0000-0002-0646-8670"]},"institutions":[{"id":"https://openalex.org/I158818660","display_name":"University of Puerto Rico, Medical Sciences Campus","ror":"https://ror.org/00h25w961","country_code":"PR","type":"education","lineage":["https://openalex.org/I158818660","https://openalex.org/I200399037"]},{"id":"https://openalex.org/I200399037","display_name":"University of Puerto Rico System","ror":"https://ror.org/02yg0nm07","country_code":"PR","type":"education","lineage":["https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Michael J. Rivera-Robles","raw_affiliation_strings":["1University of Puerto Rico School of Medicine, San Juan, PR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Puerto Rico School of Medicine, San Juan, PR;","institution_ids":["https://openalex.org/I158818660","https://openalex.org/I200399037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006846307","display_name":"Pablo E. Vivas\u2010Mej\u00eda","orcid":"https://orcid.org/0000-0002-2001-857X","observed_orcids":["https://orcid.org/0000-0002-2001-857X"]},"institutions":[{"id":"https://openalex.org/I200399037","display_name":"University of Puerto Rico System","ror":"https://ror.org/02yg0nm07","country_code":"PR","type":"education","lineage":["https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Pablo E. Vivas-Mejia","raw_affiliation_strings":["2University of Puerto Rico, San Juan, PR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Puerto Rico, San Juan, PR;","institution_ids":["https://openalex.org/I200399037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017567149","display_name":"Linette Castillo\u2010Pichardo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Linette Castillo-Pichardo","raw_affiliation_strings":["3Universidad Central del Caribe, Bayamon, PR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Universidad Central del Caribe, Bayamon, PR;","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021173615","display_name":"Cornelis P. Vlaar","orcid":"https://orcid.org/0000-0001-5145-8300","observed_orcids":["https://orcid.org/0000-0001-5145-8300"]},"institutions":[{"id":"https://openalex.org/I200399037","display_name":"University of Puerto Rico System","ror":"https://ror.org/02yg0nm07","country_code":"PR","type":"education","lineage":["https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Cornelis Vlaar","raw_affiliation_strings":["4University of Puerto Rico School of Pharmacy, San Juan, PR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Puerto Rico School of Pharmacy, San Juan, PR;","institution_ids":["https://openalex.org/I200399037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112381249","display_name":"Eliud Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200399037","display_name":"University of Puerto Rico System","ror":"https://ror.org/02yg0nm07","country_code":"PR","type":"education","lineage":["https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Eliud Hern\u00e1ndez","raw_affiliation_strings":["4University of Puerto Rico School of Pharmacy, San Juan, PR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Puerto Rico School of Pharmacy, San Juan, PR;","institution_ids":["https://openalex.org/I200399037"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026855277","display_name":"Suranganie Dharmawardhane","orcid":"https://orcid.org/0000-0001-7127-1180","observed_orcids":["https://orcid.org/0000-0001-7127-1180"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suranganie Dharmawardhane","raw_affiliation_strings":["5Surangani Dharmawardhane, San Juan, PR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Surangani Dharmawardhane, San Juan, PR","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"2197","last_page":"2197"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13202","display_name":"Pharmacology and Nanomedicine Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunoliposomes","display_name":"immunoliposomes","score":0.9580000042915344},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.925000011920929},{"id":"https://openalex.org/keywords/vav2","display_name":"Vav2","score":0.746999979019165},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.9269999861717224},{"id":"https://openalex.org/keywords/liposome-encapsulation-efficiency","display_name":"liposome encapsulation efficiency","score":0.5899999737739563},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5260000228881836},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.5090000033378601},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.5979999899864197},{"id":"https://openalex.org/keywords/egfr-signaling","display_name":"EGFR signaling","score":0.5929999947547913},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.5410000085830688},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.35199999809265137}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.669384241104126},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5976361036300659},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5920503735542297},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5525748133659363},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5433207154273987},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5019593238830566},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.49338069558143616},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4927399456501007},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4672175645828247},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45916399359703064},{"id":"https://openalex.org/C126619667","wikidata":"https://www.wikidata.org/wiki/Q901088","display_name":"Guanine nucleotide exchange factor","level":3,"score":0.4332856237888336},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4332493245601654},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4298367202281952},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3316826820373535},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30742502212524414},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.293432354927063},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2659173011779785},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24672666192054749},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1797468364238739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1504732370376587},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-2197","doi":"https://doi.org/10.1158/1538-7445.am2017-2197","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2197","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2740072477","https://openalex.org/W2402892045","https://openalex.org/W3176075357","https://openalex.org/W2066767494","https://openalex.org/W2478632560","https://openalex.org/W2400109217","https://openalex.org/W2966981733","https://openalex.org/W2083362872","https://openalex.org/W3175012371","https://openalex.org/W2886623927"],"abstract_inverted_index":{"Abstract":[0],"Due":[1],"to":[2,111,277,289,309,335,361,370,410],"the":[3,20,36,40,102,109,124,148,186,197,208,222,249,279,282,291,296,327,392,403,412,441,454],"critical":[4],"need":[5],"for":[6,185,219,402,440,457],"improved":[7],"therapeutics":[8],"against":[9],"advanced":[10],"Stage":[11],"IV":[12],"breast":[13,66,199,269,337,365,378,395,448],"cancer,":[14],"we":[15,241],"developed":[16,184],"and":[17,53,78,87,117,131,145,245,256,285,293,301,340,356,368,408],"pre-clinically":[18],"validated":[19,372],"small":[21,32],"molecule":[22,33],"Ehop-016":[23,29,72,81,107,140,172,190,226,250,300,317,346,355,444],"as":[24,119,121,151,153,215,437],"a":[25,31,57,181,203],"potential":[26,110],"anti-metastatic":[27],"drug.":[28],"is":[30],"inhibitor":[34,443],"of":[35,115,126,189,225,258,281,295,376,382,394,405,415,435,453],"interaction":[37],"Rac":[38,303,442],"with":[39,93,171,316,322,345],"guanine":[41],"nucleotide":[42],"exchange":[43],"factor":[44,61],"(GEF)":[45],"Vav2,":[46],"which":[47],"consequently":[48],"decreases":[49],"invasive":[50],"actin":[51],"structures":[52],"cellular":[54],"migration.":[55],"In":[56,287,348],"human":[58,267],"epidermal":[59],"growth":[60],"receptor":[62],"2":[63],"(HER2)":[64],"type":[65,447],"cancer":[67,84,133,143,200,270,338,366,396,449],"model":[68],"in":[69,91,147,157,166,266,298,313,364,373,391,445],"nude":[70],"mice,":[71],"inhibits":[73,141],"mammary":[74,192],"tumor":[75,149],"growth,":[76],"angiogenesis,":[77],"metastasis.":[79],"Moreover,":[80],"reduces":[82],"HER2++":[83],"cell":[85,271],"viability":[86],"migration,":[88],"individually":[89],"or":[90,96,319],"combination":[92],"anti":[94],"HER2":[95,116,238,260,446],"EGFR":[97],"directed":[98,206],"therapeutics.":[99],"By":[100],"inhibiting":[101,302,341],"key":[103],"signaling":[104,113,122],"intermediate":[105],"Rac,":[106,130,342],"has":[108,358,387],"block":[112],"downstream":[114],"EGFRs,":[118],"well":[120,152],"via":[123],"myriad":[125],"receptors":[127],"that":[128,139,326],"activate":[129],"inhibit":[132],"progression.":[134],"Our":[135],"new":[136],"results":[137],"demonstrate":[138],"both":[142],"cells":[144,314,339],"leukocytes":[146],"microenvironment,":[150],"cytokine":[154],"levels":[155],"(IL-6)":[156],"mouse":[158],"plasma.":[159],"Even":[160],"though":[161],"these":[162],"characteristics":[163],"are":[164,330],"desirable":[165],"anticancer":[167],"agents,":[168],"systemic":[169],"therapy":[170],"may":[173,399],"adversely":[174],"affect":[175],"normal":[176],"immune":[177],"system":[178,263,353,386],"function.":[179],"Therefore,":[180],"strategy":[182],"was":[183,229,264],"targeted":[187,216,239,261,384],"delivery":[188,217,262,352,385,438],"into":[191,248],"tumors,":[193],"using":[194,231,274],"nanoliposomes":[195],"containing":[196,251,354],"current":[198,416],"therapeutic,":[201],"Trastuzumab,":[202],"monoclonal":[204],"antibody":[205],"at":[207,333],"HER2.":[209],"We":[210],"tested":[211,230],"various":[212],"nanoliposome":[213],"formulations":[214],"systems":[218],"Ehop-016.":[220,323],"First,":[221],"encapsulation":[223],"efficiency":[224],"loaded":[227],"liposomes":[228,321,329],"different":[232],"drug":[233],"loading":[234],"methods.":[235],"To":[236],"obtain":[237],"liposomes,":[240],"prepared":[242],"Trastuzumab-lipid":[243],"conjugates":[244],"incorporated":[246],"them":[247],"liposomes.":[252],"The":[253,380],"binding,":[254],"internalization":[255],"selectivity":[257,294],"our":[259,350],"verified":[265],"metastatic":[268,377],"lines,":[272],"by":[273],"fluorescence":[275],"microscopy":[276],"assess":[278],"co-staining":[280],"lipid":[283],"bilayer":[284],"Trastuzumab.":[286],"order":[288],"evaluate":[290],"effectiveness":[292],"immunoliposomes":[297,436],"delivering":[299],"activity,":[304],"pull-down":[305],"assays":[306],"were":[307],"performed":[308],"detect":[310],"active":[311],"Rac-GTP":[312],"treated":[315],"alone":[318],"Trastuzumab-conjugated":[320,328],"Results":[324],"show":[325],"more":[331],"selective":[332],"binding":[334],"HER2+":[336],"than":[343],"treatment":[344,404],"alone.":[347],"summary,":[349],"novel":[351],"Trastuzumab":[357],"been":[359],"shown":[360],"be":[362,371,400],"effective":[363],"cells,":[367],"needs":[369],"animal":[374],"models":[375],"cancer.":[379],"development":[381],"this":[383],"implications,":[388],"not":[389],"only":[390],"field":[393],"therapeutics,":[397],"but":[398],"adapted":[401],"other":[406],"diseases,":[407],"used":[409],"overcome":[411],"side":[413],"effects":[414],"treatments.":[417],"Citation":[418],"Format:":[419],"Michael":[420],"J.":[421],"Rivera-Robles,":[422],"Pablo":[423],"E.":[424],"Vivas-Mejia,":[425],"Linette":[426],"Castillo-Pichardo,":[427],"Cornelis":[428],"Vlaar,":[429],"Eliud":[430],"Hern\u00e1ndez,":[431],"Suranganie":[432],"Dharmawardhane.":[433],"Characterization":[434],"vehicles":[439],"[abstract].":[450],"In:":[451],"Proceedings":[452],"American":[455],"Association":[456],"Cancer":[458,471],"Research":[459],"Annual":[460],"Meeting":[461],"2017;":[462],"2017":[463],"Apr":[464],"1-5;":[465],"Washington,":[466],"DC.":[467],"Philadelphia":[468],"(PA):":[469],"AACR;":[470],"Res":[472],"2017;77(13":[473],"Suppl):Abstract":[474],"nr":[475],"2197.":[476],"doi:10.1158/1538-7445.AM2017-2197":[477]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2017-08-08T00:00:00"}